ÂÜÀòÂÒÂ×

Hilary Nelson is an experienced professional in the pharmaceutical industry, currently serving as the Head of Clinical Development Operations at Prolaio. With a background in clinical operations, she previously held roles at companies such as Bristol Myers Squibb, MyoKardia, Genentech, and Parker Institute for Cancer Immunotherapy. Hilary's expertise includes leading integration activities, operational leadership in clinical trials, and clinical program management. She holds a BA degree from Smith College.